Literature DB >> 10556551

A sensitive, non-radioactive quantitative method for measuring IL-4 and IL-4delta2 mRNA in unstimulated cells from multiple clinical samples, using nested RT-PCR.

G T Seah1, G A Rook.   

Abstract

Measurements of IL-4 mRNA directly from clinical samples are technically difficult as IL-4 is a low copy number cytokine. Moreover, most existing studies involving RT-PCR are confused by the use of primers which simultaneously amplify cDNA of IL-4 and its splice-variant (IL-4delta2). We describe a sensitive nested RT-PCR method to quantify mRNA expression of IL-4 and IL-4delta2 separately. It involves a simple method of generating cRNA standards without cloning. The use of external synthetic RNA standards, for which we validate that amplification kinetics are equivalent to the target, obviates the need for multiple sample dilutions. The assay is sensitive enough to measure IL-4 and IL-4delta2 mRNA expression in unstimulated PBMCs of normal subjects, and the reproducibility and throughput make this assay suitable for use in clinical studies with multiple samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556551     DOI: 10.1016/s0022-1759(99)00084-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  The 6-kilodalton early secreted antigenic target-responsive, asymptomatic contacts of tuberculosis patients express elevated levels of interleukin-4 and reduced levels of gamma interferon.

Authors:  Abebech Demissie; Liya Wassie; Markos Abebe; Abraham Aseffa; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  The molecular mechanism of human resistance to HIV-1 infection in persistently infected individuals--a review, hypothesis and implications.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

3.  Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; L Pavon; E H Orozco; J Rangel; G A Rook
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 4.  Regulation of inflammation by interleukin-4: a review of "alternatives".

Authors:  Irina G Luzina; Achsah D Keegan; Nicola M Heller; Graham A W Rook; Terez Shea-Donohue; Sergei P Atamas
Journal:  J Leukoc Biol       Date:  2012-07-10       Impact factor: 4.962

5.  Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation.

Authors:  Helen A Fletcher; Patrick Owiafe; David Jeffries; Philip Hill; Graham A W Rook; Alimuddin Zumla; T Mark Doherty; Roger H Brookes
Journal:  Immunology       Date:  2004-08       Impact factor: 7.397

6.  Helicobacter pylori cag pathogenicity island is associated with reduced expression of interleukin-4 (IL-4) mRNA and modulation of the IL-4delta2 mRNA isoform in human gastric mucosa.

Authors:  Barbara Orsini; Barbara Ottanelli; Amedeo Amedei; Elisabetta Surrenti; Marco Capanni; Gianfranco Del Prete; Andrea Amorosi; Stefano Milani; Mario Milco D'Elios; Calogero Surrenti
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

7.  Ex vivo cytokine mRNA levels correlate with changing clinical status of ethiopian TB patients and their contacts over time.

Authors:  Liya Wassie; Abebech Demissie; Abraham Aseffa; Markos Abebe; Lawrence Yamuah; Hiwot Tilahun; Beyene Petros; Graham Rook; Alimuddin Zumla; Peter Andersen; T Mark Doherty
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.